Interventional Cardiology & Surgery
News
Abrupt increase noted in LVAD thrombosis
Major finding: The rate of pump thrombosis was stable at approximately 2.2% for several years, then rose steeply after March 2011 to 8.4%; the...
News
Substrate ablation shows no advantage for A fib
Major finding: Substrate ablation failed to show efficacy compared with conventional pulmonary vein isolation for patients with atrial...
Conference Coverage
Noninvasive coronary test accurate for lesion-specific ischemia
Major finding: The per-patient AUC was 0.82 with the FFRCT test, significantly better than 0.63 with CT angiography.Data source: A prospective,...
Conference Coverage
CORAL: No added benefit with renal stenting vs. medication alone
Major finding: The rate of a primary composite endpoint did not differ significantly between the renal-artery stent and control groups (35.1% and...
Conference Coverage
Mitral valve repair no better than replacement
Major Finding: The primary end point – the degree of LV reverse remodeling, as measured by the left ventricular end-systolic volume index on...
Conference Coverage
First U.S. TAVR experience fares well post-market
Major finding: The 30-day death rate was 7.6% and stroke rate 2.8%.Data source: A retrospective analysis of 7,710 patients undergoing post-...
Conference Coverage
Improved outcomes with CoreValve in extreme-risk patients
Major finding: The rate of all-cause mortality or stroke at 1 year was 26%, compared with an objective performance goal of 43%. Data source: Study...
News
Gastric bypass associated with greatest improvement in cardiac risk factors
Major finding: Gastric bypass showed greater improvement in all cardiovascular risk factors 1 year postoperatively.Data source: Prospective...
News
Limited neonatal benefit from later delivery in congenital heart disease
Major finding: There were no significant differences between 2004-2008 and 2010 data in 5-minute APGAR scores (8.5 vs. 8.6; P = .11), median...
Commentary
Medical conferences going digital
News
Shorter antiplatelet therapy after stenting found noninferior
Major finding: The incidence at 12 months of a composite of adverse events was 6% in patients randomized to 3 months of DAPT and 5.8% in those...